ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹753 Cr | ₹801 Cr | ₹656 Cr | ₹657 Cr | ₹674 Cr |
What is the latest Contingent Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹753 Cr |
Mar2023 | ₹801 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹657 Cr |
Mar2020 | ₹674 Cr |
How is Contingent Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹753 Cr | -5.98 | |
Mar2023 | ₹801 Cr | 22.19 | |
Mar2022 | ₹656 Cr | -0.24 | |
Mar2021 | ₹657 Cr | -2.46 | |
Mar2020 | ₹674 Cr | - |
Compare Contingent Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹83,655.5 Cr | -1.6% | -5.8% | -14.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -1.6% |
-5.8% |
-14.5% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses